Stock futures are little changed as traders brace for January consumer inflation report: Live updates

Stock futures are little changed as traders brace for January consumer inflation report: Live updates


Orange juice futures extend losing streak

Orange juice futures (MAR) were lower again Tuesday, marking their eighth consecutive negative session. OJ hit a low of 385.50 cents per pound, its lowest level since May 9, 2024. This pullback comes despite futures reaching all-time highs in mid-December.

Market observers are surprised by the recent downturn, given ongoing supply constraints in Florida and Brazil. On Tuesday, the USDA revised its Florida orange production forecast downward to 11.5 million boxes—4% lower than the previous estimate and a 36% drop from last season.

Three key factors may be driving the decline, according to Danny Munch, an economist at the American Farm Bureau Federation:

First, orange juice prices have risen so high that consumers and food manufacturers may be shifting to alternatives, a classic case of demand destruction. This trend is exacerbated by growing concerns around sugar content in food and beverages.

Second, traders may believe that prices have peaked and production will eventually rebound. With OJ futures still well above five- and ten-year averages, investors could be taking profits, adding to the selling pressure.

Lastly, a strong dollar and potential tariff concerns make imported orange juice relatively cheaper. This currency effect could be softening price pressures despite supply tightness.

—Nick Wells

Stocks making the biggest moves after hours

Check out some of the companies making headlines in extended trading:

  • DoorDash — The food delivery stock traded nearly 6% higher after better-than-expected revenue for the fourth quarter. DoorDash reported revenue of $2.87 billion in its most recent quarter, while analysts surveyed by LSEG forecast $2.84 billion.
  • Gilead Sciences — The biopharmaceutical stock advanced 4% after fourth-quarter results surpassed analysts’ estimates on the top and bottom lines. Gilead notched adjusted earnings per share of $1.90 on revenue of $7.57 billion. Analysts polled by LSEG were looking for earnings of $1.70 per share on revenue of $7.14 billion.
  • Super Micro Computer — The server builder popped more than 4% even as the company slashed its fiscal 2025 full-year revenue guidance. Super Micro now sees full-year revenue ranging between $23.5 billion and $25 billion, while analysts polled by LSEG called for $24.92 billion. The company also said it thinks it will be able to file its delayed annual report by Feb. 25.

Read the full list here.

— Brian Evans

Stock futures open little changed

Stock futures were little changed on Tuesday as investors look toward the January consumer price index report.

Futures tied to the Dow Jones Industrial Average ticked down 7 points, or 0.02%. S&P 500 futures slipped 0.02%, while Nasdaq 100 futures were 0.05% higher.

— Brian Evans



Source

Ex-Google CEO Eric Schmidt warns AI models can be hacked: ‘They learn how to kill someone’
World

Ex-Google CEO Eric Schmidt warns AI models can be hacked: ‘They learn how to kill someone’

Google’s former CEO Eric Schmidt spoke at the Sifted Summit on Wednesday 8, October. Bloomberg | Bloomberg | Getty Images Google‘s former CEO Eric Schmidt has issued a stark reminder about the dangers of AI and how susceptible it is to being hacked. Schmidt, who served as Google’s chief executive from 2001 to 2011, warned […]

Read More
Rare earths stocks surge after China tightens grip on global supplies
World

Rare earths stocks surge after China tightens grip on global supplies

A wheel loader operator fills a truck with ore at the MP Materials rare earth mine in Mountain Pass, California, U.S. January 30, 2020. Steve Marcus | Reuters Shares of U.S. rare earth and critical mineral miners surged Thursday after China tightened restrictions on exports, fuelling market speculation that the Trump administration will move more […]

Read More
Novo Nordisk shares slip after pharma giant announces .7 billion U.S. acquisition
World

Novo Nordisk shares slip after pharma giant announces $4.7 billion U.S. acquisition

LONDON — Shares of Danish pharmaceutical giant Novo Nordisk fell 1.1% on Thursday after the company announced plans to acquire U.S. biotech firm Akero Therapeutics. The deal will see Novo pay $54 per share, valuing Akero at $4.7 billion, with the acquisition also including a contingent value right of $6 per share, potentially adding another […]

Read More